Home › Companies › AQUESTIVE THERAPEUTICS INC. › 2023-2024
At AQUESTIVE THERAPEUTICS INC.'s shareholder meeting held June 20, 2024, in the 2023-2024 proxy season, 60 asset managers reported how they voted in their SEC Form N-PX filings, covering 242 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of our named executive officers. — AQUESTIVE THERAPEUTICS INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AQUESTIVE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 21, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AQUESTIVE THERAPEUTICS INC.’s Form 8-K, filed June 21, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 20, 2024: 6 items on AQUESTIVE THERAPEUTICS INC.’s Form 8-K, filed June 21, 2024: 2 approved · 4 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AQUESTIVE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AQUESTIVE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Santo J. Costa | 24,888,723 | -- | 680,370 | -- | 26,244,609 | — | Not verified | — |
| Elect Director: Julie Krop, M.D. | 21,612,732 | -- | 3,955,911 | -- | 26,244,609 | — | Not verified | — |
| Elect Director: Marco Taglietti, M.D. | 24,940,348 | -- | 628,295 | -- | 26,244,609 | — | Not verified | — |
| 2. Proposal to approve, on a non-binding advisory basis, executive compensation | 23,574,514 | 1,566,897 | 427,232 | -- | -- | 94% | Approved | — |
| 3. Proposal to recommend the frequency of advisory vote on executive compensation | 24,588,404 | -- | 267,927 | -- | -- | — | Not verified | — |
| 4. Appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 | 50,666,378 | 895,258 | 251,616 | -- | -- | 98% | Approved | — |
Source: AQUESTIVE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 21, 2024 — read the filing on EDGAR.
Each item below shows how the 60 asset managers that disclosed a AQUESTIVE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AQUESTIVE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
93% of fund votes cast · no official result
Description as filed by funds: To elect Santo J. Costa, Julie Krop, M.D. and Marco Taglietti, M.D. as Class III members of the Board of Directors, each to serve for a three-year term until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Julie Krop, M.D.
The 11 asset managers below reported 3,129,339 for, 239,835 withheld, 894 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,272,909 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 768,800 | 0 | 0 | 0 | For |
| 1290 Funds | 0 | 0 | 0 | 129,177 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 92,519 | Withhold |
| BlackRock | 74,288 | 0 | 0 | 0 | For |
| Fidelity | 12,641 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 9,097 | Withhold |
| Invesco | 0 | 0 | 0 | 9,013 | Withhold |
| John Hancock | 0 | 0 | 894 | 0 | Abstain |
| Equitable | 701 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 29 | Withhold |
100% of fund votes cast · no official result
Description as filed by funds: To elect Santo J. Costa, Julie Krop, M.D. and Marco Taglietti, M.D. as Class III members of the Board of Directors, each to serve for a three-year term until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Marco Taglietti, M.D.
The 11 asset managers below reported 3,370,068 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,272,909 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 768,800 | 0 | 0 | 0 | For |
| 1290 Funds | 129,177 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 92,519 | 0 | 0 | 0 | For |
| BlackRock | 74,288 | 0 | 0 | 0 | For |
| Fidelity | 12,641 | 0 | 0 | 0 | For |
| Victory Capital | 9,097 | 0 | 0 | 0 | For |
| Invesco | 9,013 | 0 | 0 | 0 | For |
| John Hancock | 894 | 0 | 0 | 0 | For |
| Equitable | 701 | 0 | 0 | 0 | For |
| Nationwide | 29 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To elect Santo J. Costa, Julie Krop, M.D. and Marco Taglietti, M.D. as Class III members of the Board of Directors, each to serve for a three-year term until the Company's 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Santo J. Costa
The 11 asset managers below reported 3,370,068 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,272,909 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 768,800 | 0 | 0 | 0 | For |
| 1290 Funds | 129,177 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 92,519 | 0 | 0 | 0 | For |
| BlackRock | 74,288 | 0 | 0 | 0 | For |
| Fidelity | 12,641 | 0 | 0 | 0 | For |
| Victory Capital | 9,097 | 0 | 0 | 0 | For |
| Invesco | 9,013 | 0 | 0 | 0 | For |
| John Hancock | 894 | 0 | 0 | 0 | For |
| Equitable | 701 | 0 | 0 | 0 | For |
| Nationwide | 29 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Elect Santo J. Costa
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 19,078 | 0 | 0 | 0 | For |
Fund voting reports, all 1 managers: 19,078 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 665,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 665,000 for.
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Elect Julie Krop
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 19,078 | 0 | 0 | 0 | For |
Fund voting reports, all 1 managers: 19,078 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 665,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 665,000 for.
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Elect Marco Taglietti
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 19,078 | 0 | 0 | 0 | For |
Fund voting reports, all 1 managers: 19,078 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 665,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 665,000 for.
Combines 5 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers.
AQUESTIVE THERAPEUTICS INC.’s own tally for this item (“2. Proposal to approve, on a non-binding advisory basis, executive compensation”): 23,574,514 for, 1,566,897 against — passed, per its Form 8-K filed June 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) The proposal to approve, on a non-binding advisory basis, executive compensation was approved.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,272,909 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 768,800 | 0 | 0 | 0 | For |
| 1290 Funds | 129,177 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 92,519 | 0 | 0 | Against |
| BlackRock | 74,288 | 0 | 0 | 0 | For |
| Charles Schwab | 19,078 | 0 | 0 | 0 | For |
| Fidelity | 12,641 | 0 | 0 | 0 | For |
| Victory Capital | 9,097 | 0 | 0 | 0 | For |
| Invesco | 9,013 | 0 | 0 | 0 | For |
| John Hancock | 894 | 0 | 0 | 0 | For |
| Equitable | 701 | 0 | 0 | 0 | For |
| Nationwide | 29 | 0 | 0 | 0 | For |
Fund voting reports, all 12 managers: 3,296,627 for, 92,519 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VR Adviser, LLC | 5,555,555 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 2,220,127 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 1,545,300 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 665,000 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 500,000 | 0 | 0 | 0 | For |
| BlackRock | 491,647 | 0 | 0 | 0 | For |
| Bracebridge Capital, LLC | 428,571 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 383,410 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 377,362 | 0 | 0 | 0 | For |
| Latash Investments, LLC | 243,134 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 213,148 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 115,805 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 100,762 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 98,019 | 0 | 0 | Against |
| Renaissance | 74,924 | 0 | 0 | 0 | For |
| Beacon Pointe Advisors, LLC | 60,000 | 0 | 0 | 0 | For |
| EAM Investors, LLC | 56,739 | 0 | 0 | 0 | For |
| Northern Trust | 46,725 | 0 | 0 | 0 | For |
| Winton Capital Management Ltd | 39,767 | 0 | 0 | 0 | For |
| State Street | 34,256 | 0 | 0 | 0 | For |
| Vanguard | 20,262 | 0 | 0 | 0 | For |
| Man Group plc | 19,880 | 0 | 0 | 0 | For |
| Charles Schwab | 19,078 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 17,513 | 0 | 0 | 0 | For |
| Two Sigma | 13,937 | 0 | 0 | 0 | For |
Institutional-manager reports, all 50 managers: 13,348,873 for, 98,059 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To cast a non-binding advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| 1290 Funds | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 12 managers: 3,389,146 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VR Adviser, LLC | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Laurion Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Altium Capital Management LP | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Janney Montgomery Scott LLC | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| Latash Investments, LLC | 0 | 0 | 0 | 0 | -- |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 0 | 0 | 0 | -- |
| ENVESTNET ASSET MANAGEMENT INC | 0 | 0 | 0 | 0 | -- |
| Corient Private Wealth LLC | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Beacon Pointe Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| EAM Investors, LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Winton Capital Management Ltd | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Trust Point Inc. | 13,771 | 0 | 0 | 0 | For |
Institutional-manager reports, all 48 managers: 13,771 for, 12,995,890 1 year. Showing the 25 largest; every one is in the interactive database (link above).
100% of fund votes cast · no official result
The 3 asset managers below reported 76,064 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 67,088 | 0 | 0 | 0 | For |
| Dixon Mitchell Investment Counsel Inc. | 8,000 | 0 | 0 | 0 | For |
| Uniplan Investment Counsel, Inc. | 976 | 0 | 0 | 0 | For |
— of fund votes cast · no official result
Description as filed by funds: Advisory Vote on Say on Pay Frequency
The 2 asset managers below reported 68,064 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0 | 0 | 0 | 0 | -- |
| Uniplan Investment Counsel, Inc. | 0 | 0 | 0 | 0 | -- |
— of fund votes cast · no official result
Description as filed by funds: To cast an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers
The 2 asset managers below reported 8,700 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OMERS ADMINISTRATION Corp | 0 | 0 | 0 | 0 | -- |
| BOFA SECURITIES, INC. | 0 | 0 | 0 | 0 | -- |
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To ratify the appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024.
AQUESTIVE THERAPEUTICS INC.’s own tally for this item (“4. Appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024”): 50,666,378 for, 895,258 against — passed, per its Form 8-K filed June 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(4) The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 was ratified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,272,909 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 768,800 | 0 | 0 | 0 | For |
| 1290 Funds | 129,177 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 92,519 | 0 | 0 | 0 | For |
| BlackRock | 74,288 | 0 | 0 | 0 | For |
| Charles Schwab | 19,078 | 0 | 0 | 0 | For |
| Fidelity | 12,641 | 0 | 0 | 0 | For |
| Victory Capital | 9,097 | 0 | 0 | 0 | For |
| Invesco | 9,013 | 0 | 0 | 0 | For |
| John Hancock | 894 | 0 | 0 | 0 | For |
| Equitable | 701 | 0 | 0 | 0 | For |
| Nationwide | 29 | 0 | 0 | 0 | For |
Fund voting reports, all 12 managers: 3,389,146 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 665,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 665,000 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 91,038,532 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.50% |
| 2 | FRANKLIN STRATEGIC SERIES | 0.84% |
| 3 | 1290 Funds | 0.14% |
| 4 | BRIDGEWAY FUNDS INC | 0.10% |
| 5 | BlackRock | 0.08% |
| 6 | Charles Schwab | 0.02% |
| 7 | Fidelity | 0.01% |
| 8 | Victory Capital | <0.01% |
| 9 | Invesco | <0.01% |
| 10 | John Hancock | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | VR Adviser, LLC | 6.10% |
| 2 | FRANKLIN ADVISERS INC | 2.44% |
| 3 | Laurion Capital Management LP | 1.70% |
| 4 | Altium Capital Management LP | 0.73% |
| 5 | DAFNA Capital Management LLC | 0.55% |
| 6 | BlackRock | 0.54% |
| 7 | Bracebridge Capital, LLC | 0.47% |
| 8 | Janney Montgomery Scott LLC | 0.42% |
| 9 | STIFEL NICOLAUS & CO INC \MO\ | 0.41% |
| 10 | Latash Investments, LLC | 0.27% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Douglas K. Bratton | 11.11% | DEF14A |
| BRATTON DOUGLAS K | 11.07% | 13G |
| BlackRock | 7.17% | 13F |
| Vanguard Group | 6.22% | 13F |
| Entities associated with Venrock Healthcare Capital Partners III, L.P. | 6.10% | DEF14A |
| MonoLine RX II, L.P. | 3.81% | DEF14A |
| MonoLine RX III, L.P. | 2.92% | DEF14A |
| Venrock Healthcare Capital Partners III, L.P. | 2.89% | 13G |
| Franklin Templeton | 2.44% | 13F |
| Daniel Barber | 2.17% | DEF14A |
Percentages above are of 91,038,532 shares outstanding, as reported by AQUESTIVE THERAPEUTICS INC. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AQUESTIVE THERAPEUTICS INC.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
AQUESTIVE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “AQUESTIVE THERAPEUTICS (AQST) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/aquestive-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.